Cancer researchers are presently armed with extraordinary tools for understanding the genetic and environmental causes of carcinogenesis. The design, execution, and interpretation of these research projects require input from teams of scientists with a mixture of backgrounds, including molecular biology, oncology, medicine, genetics, epidemiology, and biostatistics. Individuals with trans-disciplinary education across these fields are crucial to the success of such teams. In particular, they can serve as the conduit for the integrated work necessary to accomplish some of the most promising research. However, the focused nature of existing training opportunities provides limited opportunities for investigators to obtain the knowledge that bridges these disciplines. To address this issue, we propose developing an inter-institutional training program in Genetic &Molecular Epidemiology of Cancer (GMEC). Mentors and research training opportunities will come from major academic and research institutions in the San Francisco Bay Area, including the University of California, San Francisco and Berkeley, Kaiser Permanente and the Northern California Cancer Center. The proposed program is uniquely suited to the R25T grant mechanism because it will train scientists in the interdisciplinary field of genetic and molecular epidemiology. More specifically, the GMEC program will blend together in a highly interactive fashion a group of mentors and trainees from cancer research, molecular biology, genetics, epidemiology, biostatistics, and pharmacogenomics. The program is defined by a specialized core curriculum, additional educational experiences, and focused research projects with multiple mentors. Each trainee will also be required to extend their research experience by writing a mock NIH proposal. Individuals trained in this program will have the skills vital to understanding the causes of disease, ultimately providing valuable information for the treatment and prevention of cancer.
| Zhang, Chenan; Wiemels, Joseph L; Hansen, Helen M et al. (2018) Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk. Cancer Epidemiol Biomarkers Prev 27:1151-1158 |
| Wu, Yi-Hsuan; Graff, Rebecca E; Passarelli, Michael N et al. (2018) Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics. Cancer Epidemiol Biomarkers Prev 27:75-85 |
| Graff, Rebecca E; Cho, Eunyoung; Preston, Mark A et al. (2018) Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts. Cancer Epidemiol Biomarkers Prev 27:979-982 |
| Graff, Rebecca E; Ahearn, Thomas U; Pettersson, Andreas et al. (2018) Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:193-200 |
| Graff, Rebecca E; Sanchez, Alejandro; Tobias, Deirdre K et al. (2018) Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies. Diabetes Care 41:1432-1437 |
| Ferreira, Manuel A R; Vonk, Judith M; Baurecht, Hansjörg et al. (2018) Eleven loci with new reproducible genetic associations with allergic disease risk. J Allergy Clin Immunol : |
| Stopsack, Konrad H; Gonzalez-Feliciano, Amparo G; Peisch, Samuel F et al. (2018) A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status. Cancer Epidemiol Biomarkers Prev 27:1231-1233 |
| Rashkin, Sara R; Chua, Katherina C; Ho, Carol et al. (2018) A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). Clin Pharmacol Ther : |
| Majumdar, Arunabha; Haldar, Tanushree; Bhattacharya, Sourabh et al. (2018) An efficient Bayesian meta-analysis approach for studying cross-phenotype genetic associations. PLoS Genet 14:e1007139 |
| Zhang, Chenan; de Smith, Adam J; Smirnov, Ivan V et al. (2017) Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma. J Neurooncol 135:237-244 |
Showing the most recent 10 out of 125 publications
